12:00 AM
 | 
Apr 28, 2014
 |  BC Week In Review  |  Company News  |  Other News

Zogenix neurology news

Massachusetts Gov. Deval Patrick said doctors are now required to check a patient's controlled-substance history through a statewide prescription monitoring program (PMP) prior to prescribing Zogenix's Zohydro ER hydrocodone bitartrate for pain drug. The program tracks dispensing information on controlled substances scheduled by the U.S. Drug Enforcement Agency as class II through class V scheduled drugs. Zohydro ER - an oral, non-abuse deterrent, extended-release (ER) formulation of hydrocodone - is a class II scheduled drug. In Massachusetts, a prescription...

Read the full 382 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >